Skip to main content
SpringerLink
Log in

Complement resistance in microbes

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Blaser MJ, Smith PF, Repine JE, Joiner KA (1988) Pathogenesis ofCampylobacter fetus infections. Failure of encapsulatedCampylobacter fetus to bind C3b explains serum and phagocytosis resistance. J Clin Invest 81:1434

    PubMed  Google Scholar 

  2. Bliska JB, Falkow S (1992) Bacterial resistance to complement killing mediated by the ail protein ofYersinia enterocolitica. Proc Nat Acad Sci USA 89:3561

    PubMed  Google Scholar 

  3. Briles DE, Crain MJ, Gray BM, Forman C, Yother J (1992) Strong association between capsular type and virulence for mice among human isolates ofStreptococcus pneumoniae. Infect Immun 60:111

    PubMed  Google Scholar 

  4. Brown EJ, Hosea SW, Hammer CH, Burch CG, Frank MM (1982) A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia. J Clin Invest 69:85

    PubMed  Google Scholar 

  5. Brown EJ, Joiner KA, Gaither TA, Hammer CH, Frank MM (1983) The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system. J Immunol 131:409

    PubMed  Google Scholar 

  6. Cannon JG, Lee TJ, Guymon LF, Sparling PF (1981) Genetics of serum resistance inNeisseria gonorrhoeae: the sac-1 genetic locus. Infect Immun 32:547

    PubMed  Google Scholar 

  7. Chen CC, Cleary PP (1990) Complete nucleotide sequence of the streptococcal 5a peptidase gene ofStreptococcus pyogenes. J Biol Chem 265:3161

    PubMed  Google Scholar 

  8. Cooper NR (1991) Complement evasion strategies of microorganisms. Immunol Today 12:327

    PubMed  Google Scholar 

  9. Cross AS, Kim KS, Wright DC, Sadoff JC, Gemiski P (1986) Role of lipopolysaccharide and capsule in the serum resistance of bacteremic strains ofE. coli. J Infect Dis 154:497

    PubMed  Google Scholar 

  10. Dankert JR (1989) Complement-mediated inhibition of function in complement resistantEscherichia coli. J Immunol 142:1591

    PubMed  Google Scholar 

  11. Edwards JE Jr, Gaither TA, O'Shea JJ, Rotrosen D, Lawley TJ, Wright SA, Frank MM, Green I (1986) Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors. J Immunol 137:3577

    PubMed  Google Scholar 

  12. Fearon DT (1978) Regulation by membrane sialic acid of beta 1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. Proc Natl Acad Sci USA 75:1971

    PubMed  Google Scholar 

  13. Fitzgerald TJ (1987) Activation of the classical and alternative pathways of complement byTreponema pallidum subsp pallidum andTreponema vincentii. Infect Immun 55:2066

    PubMed  Google Scholar 

  14. Frank MM (1990) Complement in host defense against bacterial infections. In: Ayoub EM, Cassell GH, Branche WC, Henry TJ (eds) Microbial determinants of virulence and host response. American Society for Microbiology, Washington, D.C.

    Google Scholar 

  15. Frank MM (1992) The mechanism by which microorganisms avoid complement attack. Curr Opin Immunol 4:14

    PubMed  Google Scholar 

  16. Frank MM, Fries LF (1988) The role of complement in defense against bacterial disease. Balliers Clin Immunol Allergy 2:335

    Google Scholar 

  17. Frank MM, Joiner KA, Hammer CA (1987) The function of antibody and complement in the lysis of bacteria. Rev Infect Dis 9 [Suppl 5]: S537

    PubMed  Google Scholar 

  18. Friedman HM, Cohen GH, Eisenberg RJ, Seidel CA, Cines DB (1984) Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature 309:633

    PubMed  Google Scholar 

  19. Fuhrman SA, Joiner KA (1989)Toxoplasma gondii: mechanism of resistance to complement mediated killing. J Immunol 142:940

    PubMed  Google Scholar 

  20. Galdiero F, Sommese L, Capasso C, Galdiero M, Tufano MA (1991) Serum-mediated killing ofSalmonella typhimurium andEscherichia coli mutants which share a different content of major proteins. Microbiologica 14:119

    PubMed  Google Scholar 

  21. Grossman N, Joiner KA, Frank MM, Leive L (1986) C3b binding but not its breakdown is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from Salmonellae. J Immunol 136:2208

    PubMed  Google Scholar 

  22. Grossman N, Leive L (1984) Complement activation via the alternative pathway by purified Salmonella lipopolysaccharide is affected by its structure but not its O-antigen length. J Immunol 132:376

    PubMed  Google Scholar 

  23. Hackett J, Reeves P, Mathan V (1987) Mediation of serum resistance inSalmonella typhimurium by an 11-kilodalton polypeptide encoded by the cryptic plasmid. J Infect Dis 155:540

    PubMed  Google Scholar 

  24. Hamadeh RM, Jarvis GA, Galili U, Mandrell RE, Zhou P, Griffis JM (1992) Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces. J Clin Invest 89:1223

    PubMed  Google Scholar 

  25. Heffernan EJ, Reed S, Hackett J, Fierer J, Roudier C, Guiney D (1992) Mechanism of resistance to complement-mediated killing of bacteria encoded by theSalmonella typhimurium virulence plasmid gene rck. J Clin Invest 90:953

    PubMed  Google Scholar 

  26. Hildebrandt JF, Mayer LW, Want SP, Buchanan TM (1978)Neisseria gonorrhoeae acquire a new principal outer-membrane protein when transformed to resistance to serum bactericidal activity. Infect Immun 20:267

    PubMed  Google Scholar 

  27. Hong YQ, Ghebrehiwet B (1992) Effect ofPseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3. Clin Immunol Immunopathol 62:133

    PubMed  Google Scholar 

  28. Hong K, Kinoshita T, Takeda J, Kozono H, Pramoonjago P, Kim YU, Inoue K (1992) Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein. Infect Immun 58:2535

    Google Scholar 

  29. Horstmann RD, Fischetti VA (1987) M protein, the major virulence factor of group A streptococci inhibits alternate pathway activation by selectively binding factor H. Complement 4: 170a

  30. Horstmann RD, Sievertsen HJ, Knoblock J, Fischetti VA (1988) Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci USA 85:1657

    PubMed  Google Scholar 

  31. Iida K, Whitlow MB, Nussenzweig V (1989) Amastigotes ofTrypanosoma cruzi escape destruction by the terminal complement components. J Exp Med 169:881

    PubMed  Google Scholar 

  32. Jarvis GA, Vedros NA (1987) Sialic acid of group BNeisseria meningitidis regulates alternative complement pathway activation. Infect Immun 55:174

    PubMed  Google Scholar 

  33. Jimenez-Lucho VE, Joiner KA, Foulds J, Frank MM, Leive L (1987) C3b generation is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from salmonellae. J Immunol 139:1253

    PubMed  Google Scholar 

  34. Joiner KA (1988) Complement evasion by bacteria and parasites. Annu Rev Microbiol 42:201

    PubMed  Google Scholar 

  35. Joiner KA, Brown EJ, Frank MM (1984) Complement and bacteria: chemistry and biology in host defense. Annu Rev Immunol 2:461

    PubMed  Google Scholar 

  36. Joiner KA, Goldman RC, Hammer CH, Lieve L, Frank MM (1983) Studies on the mechanism of bacterial resistance to complement mediated killing. VI. IgG increases the bactericidal efficacy of C5b-9 forE. coli 0111B4 by acting at a step before C5 cleavage. J Immunol 131:2570

    PubMed  Google Scholar 

  37. Joiner KA, Goldman R, Schmetz M, Berger M, Hammer CH, Frank MM, Leive L (1984) A quantitative analysis of C3 binding toO-antigen capsule, lipopolysaccharide, and outer membrane protein ofE. coli 0111B4. J Immunol 132:369

    PubMed  Google Scholar 

  38. Joiner KA, Grossman N, Schmetz M, Leive L (1986) C3 Binds preferentially to long-chain LPS during alternative pathway activation bySalmonella montevideo. J Immunol 136:710

    PubMed  Google Scholar 

  39. Joiner KA, Hammer CH, Brown EJ, Cole RJ, Frank MM (1982) Sludies on the mechanism of bacterial resistance lo complement-mediated killing. I. Terminal complement components are deposited and released fromSalmonella minnesota S218 without causing bacterial death. J Exp Med 155:797

    PubMed  Google Scholar 

  40. Joiner KA, Hammer CH, Brown EJ, Frank MM (1992) Studies on the mechanism of bacterial resistance to complement mediated killing. II. C8 and C9 release C5b67 from the surface ofSalmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane. Exp Med 155:809

    Google Scholar 

  41. Joiner KA, Puentes SM, Warren KA, Scales RA, Judd RC (1989) Complement binding on serum-sensitive and serum-resistant transformants ofNeisseria gonorrhoeae: effect of presensitization with a non-bactericidal monoclonal antibody. Microb Pathog 6:343

    PubMed  Google Scholar 

  42. Joiner KA (1986) Immunobiology of the complement system. In: Ross GD (ed) An introduction for research and clinical medicine. Academic Press, Orlando, pp 183–195

    Google Scholar 

  43. Joiner KA, Scales R, Warren KA, Frank MM, Rice R (1985) Mechanism of action of blocking immunoglobulin G forNeisseria gonorrhoeae. J Clin Invest 76:1765

    PubMed  Google Scholar 

  44. Joiner KA, Warren KA, Brown EJ, Svanson J, Frank MM (1983) Studies on the mechanism of bacterial resistance to complement mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum resistant but not serum sensitiveNeisseria gonorrhoeae. J Immunol 131:1443

    PubMed  Google Scholar 

  45. Karakawa WW, Sutton A, Schneerson R, Karpas A, Vann WF (1988) Capsular antibodies induce type-specific phagocytosis of capsulatedStaphylococcus aureus by human polymorphonuclear leucocytes. Infect Immun 56:1090

    PubMed  Google Scholar 

  46. Kinoshita T (1991) Biology of complement: the overture. Immunol Today 12:291

    Google Scholar 

  47. Kochi SK, Johnson RC, Dalmasso AP (1991) Complement-mediated killing of the Lyme disease spirocheteBorrelia burgdorferi: role of antibody in the formation of an effective membrane attack complex. J Immunol 146:3964

    PubMed  Google Scholar 

  48. Kubens B5, Opferkuch W (1988) Studies on serum resistance inEscherichia coli. Zentralbl Bakteriol Mikrobiol Hyg [A] 270:52

    Google Scholar 

  49. Lancefield RC (1962) Current knowledge of type specific M antigens on group A streptococci. J Immunol 89:307

    PubMed  Google Scholar 

  50. Loos M, Clas F (1987) Antibody-independent killing of gram-negative bacteria via the classical pathway of complement. Immunol Lett 14:203

    PubMed  Google Scholar 

  51. Makela PH, Hovi M, Saxen H, Valtonen M, Valtonen V (1988) Ability to activate the alternative complement pathway as a virulence determinant inSalmonellae. In: Cabello FC, Pruzzo C (eds) Bacteria complement and the phagocytic cell. Springer, Berlin Heidelberg New York, pp 157–176

    Google Scholar 

  52. Manjula BN, Fischetti VA (1980) Tropomyosin-like seven residue periodicity in three immunologically distinct streptococcal M proteins and its implications for the antiphagocytic property of the molecule. J Exp Med 151:695

    PubMed  Google Scholar 

  53. Marikovsky M, Parizade M, Arnon R, Fishelson Z (1990) Complement regulation on the surface of cultured schistosomula and adult worms ofSchistosoma mansoni. Eur J Immunol 20:221

    PubMed  Google Scholar 

  54. Mell MA, Duke LJ, Liau D, Hash JH (1974) Biological properties of the encapsulatedStaphylococcus aureus. Infect Immun 10:389

    PubMed  Google Scholar 

  55. Merino S, Camprubi S, Alberti S, Benedi VJ, Thomas JM (1992) Mechanisms ofKlebsiella pneumoniae resistance to complement-mediated killing. Infect. Immun 60:2529

    PubMed  Google Scholar 

  56. Moll A, Manning PA, Timmis KN (1980) Plasmid determined resistance to serum bactericidal activity: a major outer membrane protein, the tra T gene product, is responsible for plasmid-specified serum resistance inEscherichia coli. Infect Immun 28:359

    PubMed  Google Scholar 

  57. Molla A, Akaike T, Maeda H (1989) Inactivation of various proteinase inhibitors and the complement system in human plasma by the 56-kilodalton proteinase fromSerratia marcescens. Infect Immun 57:1868

    PubMed  Google Scholar 

  58. Nelson RA (1953) The immune adherence phenomenon: an immunologically specific reaction between micro-organisms and erythrocytes leading to enhanced phagocytosis. Science 118:733

    PubMed  Google Scholar 

  59. Oda T, Kojima Y, Akaike T, Ijiri S, Molla A, Maeda H (1990) Inactivation of chemotactic activity of C5a by the serratial 56 kilodalton protease. Infect Immun 58:1269

    PubMed  Google Scholar 

  60. Peterson PK, Verhoef J, Sabath LD, Quie PG (1977) Effect of protein A on staphylococcal opsonization. Infect Immun 15:760

    PubMed  Google Scholar 

  61. Peterson PK, Wilkinson BJ, Kim Y, Schmeling D, Quie PG (1978) Influence of encapsulation on Staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect Immun 19:943

    PubMed  Google Scholar 

  62. Pilz D, Wachter E, Heesemann J, Brade V (1991) Evasion ofYersinia enterocolitica serotype 03 from complement-mediated killing. Behring Inst. Mitt 88:183

    PubMed  Google Scholar 

  63. Pitt J (1978) K-1 antigen ofEscherichia coli: epidemiology and serum sensitivity of pathogenic strains. Infect Immun 22:219

    PubMed  Google Scholar 

  64. Puentes SM, Sacks DL, daSilva RP, Joiner KA (1988) Complement binding by two developmental stages ofLeishmania major promastigotes varying in expression of a surface lipophosphoglycan. J Exp Med 167:887

    PubMed  Google Scholar 

  65. Roberts JS, Saunders FK, Boulnois BJ (1989) Bacterial capsules and interactions with complement and phagocytes. Biochem Soc Trans 17:462

    PubMed  Google Scholar 

  66. Ross GD, Medof ME (1985) Membrane complement receptors specific for bound fragments of C3. Adv Immunol 37:217

    PubMed  Google Scholar 

  67. Schiller NL, Hatch RA, Joiner KA (1989) Complement activation and C3 binding by serum-sensitive and serum-resistant strains ofPseudomonas aeruginosa. Infect Immun 57:1707

    PubMed  Google Scholar 

  68. Schlesinger LS, Horwitz MA (1990) Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum. J Clin Invest 85:1304

    PubMed  Google Scholar 

  69. Seidel-Dugan C, Ponce de Leon M, Friedman HM, Eisenberg RJ, Cohen GH (1990) Identification of C3b-binding regions on herpes simplex virus type 2 glycoprotein C. J Virol 64:1897

    PubMed  Google Scholar 

  70. Sj:oquist J, St:alenheimer G (1969) Protein A fromStaphylococcus aureus. IX. Complement-fixing activity of protein A-IgG complexes. J Immunol 103:467

    PubMed  Google Scholar 

  71. Stevens P, Huang SN, Welch WD, Young LS (1978) Restricted complement activation byEscherichia coli with the K-1 capsular serotype: a possible role in pathogenicity. J Immunol 21:2174

    Google Scholar 

  72. Taylor PW (1976) Immunochemical investigations of lipopolysaccharides and acidic polysaccharides from serum sensitive and serum resistant strains ofEscherichia coli isolated from urinary-tract infections. J Med Microbiol 9:405

    PubMed  Google Scholar 

  73. Taylor PW, Robinson MK (1980) Determinants that increase the serum resistance ofEscherichia coli. Infect Immun 29:278

    PubMed  Google Scholar 

  74. Tenner AJ, Zicardi RJ, Cooper NR (1984) Antibody-independent C1 activation byE. coli. J Immunol 133:886

    PubMed  Google Scholar 

  75. Toney DM, Marciano-Cabral F (1992) Alterations in protein expression and complement resistance of pathogenic Naegleria amoebae. Infect Immun 60:2784

    PubMed  Google Scholar 

  76. Unkeless JC, Wright SD (1988) Phagocytic cells: Fc gamma and complement receptors. In: Gallin JI, Goldstein IM, Snyderman R (eds) Inflammation: basic principles and clinical correlates. Raven Press, New York, pp 343–362

    Google Scholar 

  77. Van Dijk WC, Verbrugh HA, Vander Tol ME, Peters R, Verhoef J (1979) Role ofE. coli K capsular antigens during complement activation, C3 fixation, and opsonization. Infect Immun 25:603

    PubMed  Google Scholar 

  78. Vandenbosch JL, Rabert DK, Jones GW (1987) Plasmid associated resistance ofSalmonella typhimurium to complement activated by the classical pathway. Infect Immun 55:2645

    PubMed  Google Scholar 

  79. Verbrugh HA, Peterson PK, Nguyen BY, Sisson SP, Kim Y (1982) Opsonization of encapsulatedStaphylococcus aureus: the role of specific antibody and complement. J Immunol 129:1681

    PubMed  Google Scholar 

  80. Vermeulen C, Cross A, Byrne WR, Zollinger W (1988) Quantitative relationship between capsular content and killing of K-1 encapsulatedEscherichia coli. Infect Immun 56:2723

    PubMed  Google Scholar 

  81. Vishwanath S, Hackstadt T (1988) Lipopolysaccharide phase variation determines the complement mediated serum susceptibility ofCoxiella burnetii. Infect Immun 56:40

    PubMed  Google Scholar 

  82. Ward PA, Chapitis J, Conroy MC, Lepow IH (1973) Generation by bacterial proteinases of leukotactic factors from human serum and human C3 and C5. J Immunol 110:1003

    Google Scholar 

  83. Washburn RG, Bryant-Varela BJ, Julian NC, Bennett JE (1991) Differences inCryptococcus neoformans capsular polysaccharide structure influence assembly of alternative pathway C3 convertase on fungal surfaces. Mol Immunol 28:465

    PubMed  Google Scholar 

  84. Washburn RG, Hammer CH, Bennett JE (1986) Inhibition of complement by culture supernatants ofAspergillus fumigatus. J Infect Dis 154:944

    PubMed  Google Scholar 

  85. Weis JJ, Law SK, Levine BP, Cleary PP (1985) Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors. J Immunol 134:500

    PubMed  Google Scholar 

  86. Wetzler LM, Barry K, Blake MS, Gotschlich EC (1992) Gonococcal lipooligosaccharide sialylation prevents complement-dependent killing by immune sera. Infect Immun 60:39

    PubMed  Google Scholar 

  87. Whiteman LY, Marciano-Cabral F (1989) Resistance of highly pathogenicNaegleria fowleri amoebae to complement-mediated lysis. Infect Immun 57:3869

    PubMed  Google Scholar 

  88. Whitnack E, Beachey EH (1982) Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci. J Clin Invest 69:1042

    PubMed  Google Scholar 

  89. Whitnack E, Poirier TP, Beachey EH (1988) Complement-mediated opsonization of group A streptococci inhibited by the binding of fibrinogen to surface M protein fibrillae. In: Cabello FC, Pruzzo C (eds) Bacteria, complement and the phagocytic cell. Springer, Berlin Heidelberg New York, pp 201–210

    Google Scholar 

  90. Winkelstein JA, Abramovitz AS, Tomasz A (1980) Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall. J Immunol 124:2502

    PubMed  Google Scholar 

  91. Winkinson BJ, Sisson SP, Kim Y, Peterson PK (1979) Localization of the third component of complement on the cell wall of encapsulatedStaphylococcus aureus M: implications for the mechanism of resistance to phagocytosis. Infect Immun 26:1159

    PubMed  Google Scholar 

  92. Aguero ME, Cabello FC (1983) Relative contribution of CoIV plasmid and K1 antigen to the pathogenicity ofEscherichia coli. Infect Immun 40:359

    PubMed  Google Scholar 

  93. Binns MM, Davies DL, Hardy KG (1979) Cloned fragments of the plasmid CoIV,1-94 specifying virulence and serum resistance. Nature 279:778

    PubMed  Google Scholar 

  94. Binns MM, Mayden J, Levine RP (1982) Further characterization of complement resistance conferred onEscherichia coliby the plasmid genes traT of R100 and iss of CoIV,I-K94. Infect Immun 35:654

    PubMed  Google Scholar 

  95. Russo T, Moffitt M, Hammer C, Frank M (1993) Tnpho A-mediated disruption of K54 capsular polysaccharide genes inEscherichia coli confers serum sensitivity. Infect Immun 61:3578

    PubMed  Google Scholar 

  96. Timmis KN, Boulnols GJ, Bitter-Suermann D, Cabello FC (1985) Surface components ofEscherichia coli that mediate resistance to the bactericidal activities of serum and phagocytes. Curr Top Microbiol Immunol 118:197

    PubMed  Google Scholar 

  97. Weiser JN, Gotschlich EC (1991) Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1. Infect Immun 59:2252

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Duke University Medical Center, Box 3352, 27710, Durham, NC, USA

    M. Catharine Moffitt & Michael M. Frank

Authors
  1. M. Catharine Moffitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael M. Frank
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moffitt, M.C., Frank, M.M. Complement resistance in microbes. Springer Semin Immunopathol 15, 327–344 (1994). https://doi.org/10.1007/BF01837364

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01837364

Keywords

Search

Navigation